Simplex Trading, LLC Fate Therapeutics Inc Transaction History

Simplex Trading, LLC

$2.98 Billion
Q2 2024

A detailed history of Simplex Trading, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 1,482 shares of FATE stock, worth $5,290. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,482

Previous 1,620 8.52%

Holding current value

$5,290

Previous $11,000 63.64%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$3.26 - $7.08 $449 - $977	-138 Reduced 8.52%	1,482 $4,000
Q1 2024 Apr 25, 2024	BUY	$3.54 - $8.35 $605 - $1,427	171 Added 11.8%	1,620 $11,000
Q4 2023 Feb 02, 2024	BUY	$1.65 - $3.94 $1,864 - $4,452	1,130 Added 354.23%	1,449 $5,000
Q3 2023 Nov 01, 2023	SELL	$2.02 - $5.04 $18,426 - $45,974	-9,122 Reduced 96.62%	319 $0
Q2 2023 Aug 04, 2023	SELL	$4.76 - $6.59 $4,260 - $5,898	-895 Reduced 8.66%	9,441 $44,000
Q1 2023 Apr 27, 2023	BUY	$4.24 - $11.12 $37,447 - $98,211	8,832 Added 587.23%	10,336 $58,000
Q4 2022 Feb 02, 2023	BUY	$9.86 - $23.83 $1,370 - $3,312	139 Added 10.18%	1,504 $15,000
Q3 2022 Nov 04, 2022	BUY	$21.04 - $36.06 $25,079 - $42,983	1,192 Added 689.02%	1,365 $30,000
Q2 2022 Aug 03, 2022	SELL	$17.78 - $42.39 $182,138 - $434,243	-10,244 Reduced 98.34%	173 $4,000
Q1 2022 May 02, 2022	BUY	$29.67 - $60.28 $296,432 - $602,257	9,991 Added 2345.31%	10,417 $403,000
Q4 2021 Feb 23, 2022	BUY	$47.84 - $64.34 $20,379 - $27,408	426 New	426 $24,000
Q4 2020 Feb 02, 2021	SELL	$38.09 - $100.95 $734,527 - $1.95 Million	-19,284 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$30.41 - $40.5 $586,426 - $781,002	19,284 New	19,284 $770,000
Q1 2020 Apr 29, 2020	SELL	$17.28 - $31.88 $27,285 - $50,338	-1,579 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$13.39 - $20.73 $117,952 - $182,610	-8,809 Reduced 84.8%	1,579 $30,000
Q3 2019 Oct 15, 2019	SELL	$15.47 - $22.5 $5,290 - $7,695	-342 Reduced 3.19%	10,388 $161,000
Q2 2019 Jul 26, 2019	SELL	$15.61 - $20.44 $119,931 - $157,040	-7,683 Reduced 41.73%	10,730 $217,000
Q1 2019 Apr 18, 2019	BUY	$13.15 - $18.71 $131,749 - $187,455	10,019 Added 119.36%	18,413 $0
Q4 2018 Jan 16, 2019	BUY	$11.48 - $16.98 $95,054 - $140,594	8,280 Added 7263.16%	8,394 $107,000
Q3 2018 Oct 23, 2018	SELL	$8.75 - $16.29 $114,196 - $212,600	-13,051 Reduced 99.13%	114 $1,000
Q2 2018 Jul 30, 2018	SELL	$9.16 - $13.48 $149,280 - $219,683	-16,297 Reduced 55.32%	13,165 $149,000
Q1 2018 Apr 26, 2018	BUY	$6.3 - $13.77 $160,448 - $350,694	25,468 Added 637.66%	29,462 $287,000
Q4 2017 Jan 10, 2018	BUY	$3.94 - $6.64 $15,326 - $25,829	3,890 Added 3740.38%	3,994 $24,000
Q3 2017 Oct 25, 2017	BUY	$2.6 - $4.31 $270 - $448	104	104 $0

Others Institutions Holding FATE

# of Institutions

190

Shares Held

123M

Call Options Held

15K

Put Options Held

14K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $346M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Fate Therapeutics Inc Transaction History